Cargando…

Impact of COVID 19 National Lockdown on Glycaemic Control in Children and Adolescents With Type 1 Diabetes (T1DM): A Retrospective Review at a Large UK Teaching Hospital

Introduction: The coronavirus disease global pandemic led to national lockdown in the United Kingdom on 23(rd) March 2020. We compared the glycaemic control of children and adolescents with Type 1 diabetes (T1DM) at Doncaster & Bassetlaw Teaching Hospitals in the 12 weeks prior to the lockdown,...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lawrence, Neil Richard, Natarajan, Anuja, Petkar, Razia, Joseph, Lovlin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2021
Materias:	Diabetes Mellitus and Glucose Metabolism
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8089672/ http://dx.doi.org/10.1210/jendso/bvab048.701

Ejemplares similares

Glycaemic Control in Children and Adolescents With Type 1 Diabetes Following a Single Telehealth Visit:What Have We Learned From the COVID-19 Lockdown?
por: Rachmiel, Marianna, et al.
Publicado: (2021)

Inpatient Glycaemic Control is Poor in Patients Receiving Insulin Therapy
por: Reidy, Niall, et al.
Publicado: (2021)

MON-166 Excess Cardiovascular Events Despite Good Glycaemic Control
por: Ulahannan, Thomas, et al.
Publicado: (2019)

Mild Cognitive Impairment Screening in Older Adults With Type 2 DM
por: Pirela, Daniela Victoria, et al.
Publicado: (2021)

Association Between Metformin and Prevention of Dementia in T2DM Adult Patients
por: dos Santos, Natalia Moles, et al.
Publicado: (2021)

Covid Lockdown Impact on Type 1 Diabetes Health and Well-Being
por: Calma, Jamie, et al.
Publicado: (2021)

Detecting Frailty in Elderly Type 2 Diabetes Mellitus (T2DM) Patients in the Southeast of Brazil
por: Ramos-Dias, João Carlos, et al.
Publicado: (2021)

SAT-162 Hepatocyte Nuclear Factor-4α (HNF44α) as a Target to Treat DM
por: Jorge dos Santos, Gustavo, et al.
Publicado: (2019)

Effects of Evogliptin as Add on in Type 2 Diabetes (T2DM) Subjects Inadequately Controlled With Metformin and Glimepiride Combination
por: Guha, Shaibal
Publicado: (2021)

Euglycemic Diabetic Ketoacidosis Post Bariatric Surgery in Type II DM in the Setting of SGLT2-Inhibitor Use
por: Alfares, Khalid, et al.
Publicado: (2021)

The Impact of Multi-Disciplinary Input on Glycaemic Control Over Time in Children on Intensive Insulin Therapy Using Real World Prospectively Collected Data
por: Foran, Jason, et al.
Publicado: (2021)

SUN-LB112 Efficacy & Safety After Switchover to Remogliflozin in Indian T2DM Patients - a Real World Study
por: Bhattacharyya, Supratik, et al.
Publicado: (2020)

Effects of Movement Control Order (MCO) During Covid-19 Pandemic on Patients With Diabetes Mellitus (DM) in Malaysian Tertiary Centers
por: Kuan, Yueh Chien, et al.
Publicado: (2021)

Impact of Covid19 Lockdown on Glycemic Control
por: Rodriguez, Giovanna, et al.
Publicado: (2021)

SUN-150 Complications of DKA in Teaching Vs. Non-Teaching Hospitals
por: Motlaghzadeh, Yasaman, et al.
Publicado: (2019)

MON-687 Diabetic Muscle Infarction (DMI) a Rare Under-Recognised Complication of Diabetes Mellitus (DM): A Series of Three Cases
por: Dhanasekaran, Maheswaran, et al.
Publicado: (2020)

SAT-620 Left Ventricular Myocardial Deformation in T2DM Is Associated with Chronic Hyperglycemia but Not Myocardial Perfusion: A Study Based on Magnetic Resonance Imaging
por: Zhou, Fangli, et al.
Publicado: (2020)

Once Weekly Basal Insulin Fc (BIF) is Safe and Efficacious in Patients with Type 2 Diabetes Mellitus (T2DM) Previously Treated With Basal Insulin
por: Frias, Juan Pablo, et al.
Publicado: (2021)

How Did Elderly T2D Patients Cope With the Quebec Covid-19 Lockdown
por: Elstein, Jack, et al.
Publicado: (2021)

Impact of Covid-19 Lockdown Measures on Lifestyle Behavior in Children and Adolescents With Severe Obesity
por: Abawi, Ozair, et al.
Publicado: (2021)

Clinical Effectiveness and Safety of Gliclazide MR and Linagliptin Combination in the Management of Patients With T2DM and Chronic Kidney Disease (CKD) Switched From Glimepiride - a Real-World, Retrospective, Observational Study
por: Bhattacharyya, Supratik, et al.
Publicado: (2021)

An Observational Study on Glycemic Outcomes, Lifestyle and Psychosocial Health of Patients With Diabetes During Covid-19 Lockdown From Bangalore
por: Selvarajan, Raja, et al.
Publicado: (2021)

MON-615 Retrospective Analysis of the Contribution of Cannabis Usage to Diabetic Ketoacidosis at an Urban Teaching Hospital
por: Kha, Christine K, et al.
Publicado: (2020)

SUN-152 De-Intensifying Diabetic Medications in Patients with Stable HbA1c: A National Survey of Primary Care Physicians and Endocrinologists
por: Ahmad, Sara, et al.
Publicado: (2019)

ODP259 Evaluating the Efficacy and Safety of Long-Acting GLP-1 Receptor Agonist in T1DM Patients
por: Mohandas, Deene, et al.
Publicado: (2022)

THU351 Reduced Total Antixoxidant Capacity In Type 1 DM Without Chronic Complications
por: Oliveira, Sara C, et al.
Publicado: (2023)

SAT-674 Anti PD1 Induced Type 1 Diabetes
por: Naranjo, Maria Belen, et al.
Publicado: (2020)

SAT-150 Forkhead Box Protein O1 (foxo1) Regulates Hepatic Serine Protease Inhibitor B1 (serpinb1) Expression In A Cell Non-autonomous Fashion
por: El Ouaamari, Abdelfattah, et al.
Publicado: (2019)

Diabetes Does Not Worsen Outcomes of Patients Admitted for Hyperthyroidism: Analysis of the National Inpatient Sample
por: Shaka, Hafeez, et al.
Publicado: (2021)

Outcomes in Hospitalizations for Patients Admitted With Hyperosmolar Hyperglycemic State and Obesity: Analysis of National Inpatient Sample
por: Shaka, Hafeez, et al.
Publicado: (2021)

In-Hospital Outcomes in Patients With Hyperosmolar Hyperglycemic State With and Without Hypertriglyceridemia: Analysis of National Inpatient Sample
por: Velazquez, Genaro, et al.
Publicado: (2021)

SUN-128 Novel Mutation in the HNF1A Gene in Siblings Previously Diagnosed with Type 1 Diabetes
por: Raisingani, Manish, et al.
Publicado: (2019)

Impact of Atrial Fibrillation on In-Hospital Outcomes in Patients With Hyperosmolar Hyperglycemic State: Analysis of National Inpatient Sample
por: Velazquez, Genaro, et al.
Publicado: (2021)

OR22-1 Liraglutide as Add-on to SGLT2 Inhibitors in Patients with Inadequately Controlled Type 2 Diabetes (LIRA-ADD2SGLT2i): A 26-Week, Randomized, Double-Blind, Placebo-Controlled Trial
por: Blonde, Lawrence, et al.
Publicado: (2019)

MON-646 Novel Use of GLP-1 Receptor Agonist Therapy in MODY-1 (HNF4A Mutation)
por: Broome, David Tyler, et al.
Publicado: (2020)

SAT-680 Diabetes Mellitus Induced by Programmed Cell Death-1 (PD-1) Inhibitors: A Case Report
por: Abuaisha, Munder, et al.
Publicado: (2020)

MON-625 Utility of Continuous Glucose Monitoring in Children with Type 1 Diabetes: Is HbA1c Enough?
por: Owens, Lindsey L, et al.
Publicado: (2020)

Young Adult LEW.1WR1 Rats Develop Dysregulated Islet Function and Impaired Liver Insulin Responses
por: Wilkerson-Vidal, Quiana C, et al.
Publicado: (2021)

SUN-620 Gender Difference in the Outcome of Patients with Diabetes Admitted for Hyperosmolar Hyperglycemia. from the National Inpatient Sample
por: Ahmed, Fatima, et al.
Publicado: (2020)

OR14-3 The Association of Glycemic Control and Glycemic Variability with Treatment Patterns and Diabetes-Related Events in the Adult Patients (Pts) with Type 1 Diabetes (T1D): Results from the T1D Exchange Clinic Registry
por: Wysham, Carol, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_tmjtkj2m56k8s5fujmhdkqogo2